Is left ventricular hypertrophy a reliable predictor of renal and cardiac outcome in IgA nephropathy? [0.03%]
左心室肥厚能否可靠地预测IgA肾病患者的肾脏和心脏预后？
Ernesto Paoletti,Elisabetta Bussalino
Ernesto Paoletti
The changing landscape of heart failure: translating management into the modern era [0.03%]
心力衰竭的治疗现状与未来展望
Cristina Madaudo,Wasyla Ibrahim,Daniela Noakes et al.
Cristina Madaudo et al.
Heart failure (HF) is a complex clinical syndrome associated with high morbidity and mortality, accounting for approximately 2 % of total healthcare expenditures. Despite advances in pharmacological and device-based therapies, HF continues ...
Giacomo Ramponi,Marco Paganuzzi,Monica Solbiati et al.
Giacomo Ramponi et al.
A call to action: Bridging glucose monitoring and treatment gaps in inpatient diabetes care [0.03%]
行动号召：弥合住院糖尿病患者血糖监测和治疗的差距
Guillermo Umpierrez,Fernando Gomez-Peralta
Guillermo Umpierrez
Methodological considerations for interpreting the association between central systolic blood pressure and brain health. Author's reply [0.03%]
关于中心收缩压与脑健康关联的解读方法学考虑 作者回复
Zhongping Yu,Chen Liu,Fang-Fei Wei
Zhongping Yu
Theodora A Manolis,Antonis A Manolis,Apostolos Vouliotis et al.
Theodora A Manolis et al.
Epilepsy is a major noncommunicable neurological disorder, most prevalent among patients with cardiovascular (CV) disease (CVD). Epilepsy incurs a higher risk for developing CVD with an odds ratio of 2.25. CVDs can influence the function of...
Advancing beyond multimodality: integrating quantitative imaging biomarkers into the clinical workflow of cardiac amyloidosis [0.03%]
超越多模态：将定量影像生物标志物整合到心脏淀粉样变性临床工作流程中
Yonghao Jiang,Suying Wu,Yuantong Xu
Yonghao Jiang